Difficulties mastered are opportunities won.
— Winston Churchill

ISAM-Woolcock 2014 online Registration and Abstract submissions open!

Click the lung to go to the ISAM 2014 Webpage

Click the lung to go to the ISAM 2014 Webpage

The International Society for Aerosols in Medicine and the Woolcock Institute of Medical Research are proud to announce that both online registration and abstract submission for the 2014 Conference and Workshop are now open.

You can submit an abstract and/or register online now at www.woolcock.org.au/isam2014
Just follow the abstract and registration tabs! Note, early Bird registrations are open until 24th August 2014.

The conference will be held at the WIMR Headquarters on 25-26 Sept 2014 in Sydney, Australia.


The Topics for this year focus on paediatric respiratory medicine and bioequivalence of Inhaled formulations. Highlights include:

  • Emerging therapies for paediatric diseases.
  • The impact of your formulation on PK
  • Regulatory hurdles for paediatric therapy
  • In vitro in vivo correlation challenges and formulation prediction
  • Current practice and state-of-the-art for treating lung disease in children
  • Methodological approaches for IVIVC
  • Podium presentations
  • Posters sessions
  • Hands on workshop
  • Roundtable discussions
  • Conference dinner
  • Social events and networking

Early bird prices are AUD $225, $325 and $435 for students, academics and industry attendees, respectively. If you are interested in being a sponsor please contact us at isam2014@woolcock.org.au

We look forward to seeing you in September

The ISAM-Woolcock Team

 

SPIRITUS: (3-14) A Monthly update from the Respiratory Technology team at the WIMR.

This is our March 2014 update of news from the Respitech group at the WIMR.

This month, the RespiTech team have been busy developing the upcoming joint ISAM-Woolock conference in September and were pleased to announce the Keynote speakers. The program is starting to come together with a number of invited speakers and the first call for abstracts is planned for the 1st week in April. 

Eric & Michele using the new JEOL desktop SEM

In the laboratory, the team have overseen the installation of a new scanning electron microscope. The bench-top SEM will significantly enhance the groups productivity as we can immediately screen particulate systems after production, allowing us to optimise engineering processes via informed decisions. Meanwhile, the group published a paper in Drug Development and Industrial Pharmacy focussed on aersosolisation of high-dose cohesive powders intended for the treatment of bronchiectasis. This is the second paper with Pharmaxis Ltd investigating the Orbital multi-breath inhaler.

As usual, we would like to congratulate members of the team for their successes. Dr Mehra Haghi was awarded a Humboldt fellowship. This highly prestigious fellowship will allow Mehra to spend a year overseas in Prof. Claus-Michael Lehr’s lab at the University of Saarbrücken in Germany. Mehra will use this opportunity to further develop her research in the area of advanced cell biology models of the lung and immunology. At the same time, Mehra was also awarded a Asthma Australia travel award. This will allow Mehra to further develop links with like minded researchers in the areas of respiratory science. 

Meanwhile, Paul and Daniela received Honorary Appointments as Adjunct Professors at the University of Technology Sydney (UTS). Daniela and Paul have a long history of collaboration with UTS academics and will continue to build on these collaborations via a number of projects and co-supervised students at the ithree institute (Cynthia Whitchurch) and Pharmacy (Fabio Sonvico). We would also like to congratulate Michele Pozzoli who has officially transferred from Masters to PhD candidature at UTS. Michelle is supervised by Fabio, Paul and Daniela and was also awarded a $1,000 Vice Chancellors travel grant this month. He will join members of the team at RDD in Puerto Rico in May.

Respitech group on the WIMR terrace - March 2013

As usual, we would like to welcome new members/visitors and say goodbye to friends. Dave Lewis and Gemma Keegan from Chiesi returned to the Uk after a successful visit. A number of projects are already underway and the visit resulted in a number of new exciting research paths. Meanwhile Prof Carsten Ehrhardt joins us on sabbatical from Trinity College Dublin. The team are working with Carsten to develop a number of projects in the areas of applied respiratory cell molecular biology with a focus on transporters. He will give a seminar at the Institute next month. Prof Warren Finlay also visited us this month from the University of Alberta. Warren is working with the group to further establish projects in the area of nasal drug delivery. Finally, we would like to welcome Tim Cornish and Valentina Trotta to the group. Tim is undertaking an engineering honours year in the area of nasal flow path simulation and deposition and Valentina is a Cotutelle PhD student between The University of Sydney and Ferrara Universty (Italy) working in the area of anti-oxidants and respiratory therapy.

ISAM-Woolcock 2014 Joint Conference and Workshop Keynote Speakers Announced

Download the information flyer here

Download the information flyer here

The International Society for Aerosols in Medicine and the Woolcock Institute of Medical Research are proud to announce the 2014 Conference and Workshop at the WIMR Headquarters on 25-26 Sept 2014 in Sydney, Australia. The Topics for this year focus on paediatric respiratory medicine & bioequivalence of Inhaled formulations. Highlights include:

  • Emerging therapies for paediatric diseases.
  • The impact of your formulation on PK
  • Regulatory hurdles for paediatric therapy
  • The in vitro in vivo correlation challenge; formulation prediction.
  • Current practice and state-of-the-art for treating lung disease in children
  • Methodological approaches for IVIVC
  • Podium presentations
  • Posters sessions
  • Hands on workshop
  • Roundtable discussions
  • Conference dinner
  • Social events and networking

Confirmed Keynote speakers

Prof. Peter R. Byron. E Claiborne Robins Professor and Chairman Department of Pharmaceutics. Virginia Commonwealth University.

Prof Mark Everard. Winthrop Professor/McCusker Chair in Paediatric Respiratory Medicine, School of Paediatrics and Child Health, The University of Western Australia.

The call for abstracts and early bird registration will open on the 1st April 1st 2014. To learn more about the conference please visit www.woolcock.org.au/isam2014

SPIRITUS: (2-14) A Monthly update from the Respiratory Technology team at the WIMR.

shutterstock_157364768 copy.jpg

This is our February 2014 update of news from the Respitech group at the WIMR.

February has been a successful month for the RespiTech group with a number of announcements, developments and new team members.

Firstly, the National Health and Medical Council of Australia awarded members of the team a $401,708 NHMRC Development Grant, entitled ‘CSI Sydney’, to develop a formulation that targets chronic sinus infection and conduct a number of first in human imaging studies using a sinus targeting device. The grant was awarded to CIs Paul Young, Daniela Traini (RespiTech, Woolcock & Sydney Medical School USyd), Greg King (Physiology, Woolcock & Sydney Medical School USyd), Dale Bailey (Northern Clinical School, Usyd) (Ramin Rohanizadeh, Pharmacy, USyd), Cynthia Whitchurch (iThree Institute, UTS) and is partnered with a local pharmaceutical company AFT. Both The story was picked up by the ABC National radio service and local radio. Both Paul and Greg discussed the problems associated with sinus infection on a number of interviews and talk-back shows.

The RespiTech team along with the Respiratory Cellular and Molecular Biology group were also successful in receiving a grant from the Rebecca L. Cooper Medical Research Foundation. The grant, worth $22,000 will be used to purchase a electric cell-substrate impedance sensing (ECIS) instrument for studying respiratory cell cultures.

There was more reason to celebrate when the Woolcock organised a morning tea to award one of the RespiTech postdocs, Wing Hin a $10,000 ECR grant. Wing will use this seed funding to develop his research on targeted respiratory cancer therapy. 

Meanwhile, John Chan had a paper accepted in Journal of Pharmaceutical Sciences entitled “A novel inhalable form of rifapentine” This work forms the basis of the groups ongoing TB targeting research program.

RespiTech members enjoyed a number of social events in February. The Italian contingent organised a farewell pizza dinner for ‘YY, the boss’ at Fratelli Fresh while Yang organised a second outing for beer, sushi and karaoke. YY will now spend the next 12 months in Southampton with Prof Joy Conway’s group establishing a collaboration in the area of medical imaging. She will keep us updated via a new blog.

As usual we like to introduce new members of RespiTech team and welcome visitors. Matteo Padroni joins us from Ferrara, Nadine Vermeiren from the Netherlands and Emelie Britt Linnea Land is a local grad student. Matteo is working in the area of antibiotic therapy, Nadine in aerosol particle formation mechanics and Emelie on the use of Spacer in emergency room treatment. Finally, we would like to welcome visitors Dr Dave Lewis and Dr Gemma Keegan. Dave and Gemma, are from Chiesi’s Innovation centre in the UK. Dave and his team have a long history of working with our group and their visit to Australia is to firm up the focus of a number of projects including our joint ARC Linkage program and co-supervision of PhD student Yang. Welcome!

RespiTech successful in securing funding for nasal drug targeting

shutterstock_166610216.jpg

Members of the RespiTech team and Lung Physiology group at the Woolcock Institute of Medical Research (WIMR) and the University of Sydney have been successful in securing a National Health and Medical Research Council (NHMRC) Development Grant. Associate Professors Paul Young, Daniela Traini and Greg King (WIMR), along with Prof Dale Baily (Central Clinical School), Dr Ramin Rohanizadehh (Pharmacy) and A/Prof Cynthia Whitchurch (UTS iThree Institute) have been awarded $401,708 to research and develop a series of technologies for targeting chronic sinus infection.

Chronic sinus infection (CSI) is prevalent and results in severe discomfort and pain for many Australians; yet, has no specific cure or effective treatment. Our multi-disciplinary research team and an Australian health and medical research company, (AFT Pharmaceuticals) have partnered to develop a novel device that specifically targets the sinuses in conjunction with a formulation capable for simultaneously removing mucus, dispersing biofilms and killing bacteria in the nasal cavities. The Project will commence in the first quarter of 2014 and will run for 2-years.

SPIRITUS: (JAN-14) A Monthly update from the Respiratory Technology team at the WIMR.

This is our January 2014 update of news from the Respitech group at the WIMR.

Jan 2014.jpg

The RespiTech Group celebrates a year of operation this month and look forward to an exciting year ahead. In January the group has been ramping up operations for 2014 and celebrating a number of new initiatives and successes.

Firstly, Wing-Hin Lee was awarded the Woolcock Institute’s inaugural Early Career Researcher Grant. Wing will use the $10,000 grant to establish his project proposal in the area of lung cancer targeting. The group also congratulates Mehra Haghi for receiving a Travel Grant from the Thoracic Society of Australia and New Zealand. Mehra will use the award travel to South Australia in April to attend the annual meeting and present her work.

As usual we would like to welcome new members to our group. Jasper Lamers and Mary Goud have joined us from the Netherlands as visiting researchers. Jasper will be working on projects within the field of patient compliance and ‘good inhaler device use’, while Mary will be working on advanced phosphodiesterase inhibitor therapies. We would also like to welcome Khanh Huynh to the group. Khanh is an Honours student from Engineering and will spend the next year with the group studying and optimising fluid flow paths through dry powder inhaler devices using in vitro and in silica models.

The group celebrated Chinese New Year this month, with members bringing a number of dishes to enjoy, including sushi, cupcakes and beef tendon jelly. The event was also accompanied by the celebration of John Chan’s successful PhD thesis submission. We also announced the successful completion and launch of the Woolcock Video, of which a number of the group were involved in making a success. You can find the Woolcock Video, Chinese New Year and other group social activities on our Facebook Page (www.Facebook.com/RespiTech).

Lastly, we would like to congratulate YY for publishing a first author paper in AAPS Journal entitled ‘Combined Inhaled Salbutamol and Mannitol Therapy for Mucus hyper-secretion in Pulmonary Diseases’. This study utilises a number of cell-based models and in vitro techniques to study the effect of combined β-2 agonist and mannitol formulations on cilia beat frequency, muscle contraction and drug absorption.

Welcome to the Woolcock!

Members of the RespiTech team have been working with the Woolcock to produce a short video that highlights the uniqueness of our institute. You can watch the video by clicking on the image above or following the link: http://vimeo.com/respitech/welcome-to-the-woolcock

You can learn more about the Woolcock Institute of Medical Research, our clinics and research at www.woolcock.org.au. Learn more about the Respiratory Technology team at the Woolcock at www.RespiTech.org. And don't forget to like RespiTech at www.Facebook/RespiTech.

Wing-Hin awarded The Woolcock's first ECR grant

Wing-Hin Lee

Wing-Hin Lee

Wing-Hin Lee has been awarded the inaugural Woolcock ECR grant. Wing will receive $10,000 as seed funding to develop a research program within the Respiratory Technology group. The seed funding will support his proposal, entitled ' Inhalable iron oxide nanoparticles for imaging and cancer therapy: from bench to bedside', to develop an advanced nano technology based lung cancer therapy. Wing was one of 6 early career researchers who presented at the Woolcock Think Tank in November 2013 and submitted a grant proposal. The Board of the Woolcock ranked these proposals and awarded Wing the seed funding grant. All the proposals were outstanding and the Research Committee will  work with all the ECRs to develop these projects into potential external funding proposals.



SPIRITUS: (12) A Monthly update from the Respiratory Technology team at the WIMR - end of year report and one year anniversary.

Dec.jpg

This is our December update of news from the Respitech group at the WIMR.

The Respiratory Technology Team at the Woolcock Institute of Medical Research celebrate their first year of operation. The group has achieved a lot in the past 12 months. We have grown since January and  have had 22 research personal come through our doors. We have published 28 peer reviewed articles, sourced funding for a number of projects and have established wider initiatives within the community. To highlight some of the achievements over the past year the group has prepared an annual report outlining some of the initiatives and key performance outcomes. The report that can be downloaded here. Importantly, the group has partaken in a number of social events including, cook-ups, the famous hot pot adventure, all-important pub trips and a harbour cruise. To learn more about the social side of RespiTech you can always like us on Facebook  - www.facebook.com/RespiTech

In December, members of our group travelled to Edinburgh to participate at the Drug Delivery to the Lungs Conference, DDL24. Jesslynn Ooi, John Chan and Judy Loo were nominated to speak at the prestigious Pat Burnell New investigator award session. Prior to DDL, the group participated in the first ECR2STAR workshop in London. The conference was a great success and the team will be involved in developing new and and exciting early career programs in the coming year.
John Chan received a series of awards this month, including the Royal Society of NSW scholarship and best speaker at the AFPS conference in Korea. Meanwhile, YY (Hui Xin Ong) was awarded her PhD at The University of Sydney. YY was awarded an European Respiratory Society Postdoctoral fellowship and will move to the UK in early 2014 to commence a clinical focussed research project with Prof Joy Conway’s group in the area of medical imaging.

RespiTech 2013 Report.

RespiTech 2013 Report.

Also of note this month, the group announced the ISAM/Woolcock 2014 Joint Conference and workshop to be hosted in Sydney in September. The theme of the conference and further details will be announced in January via the Woolcock and ISAM websites.

Lastly, we would like to congratulate members of the group for publishing 4 peer reviewed articles this month. John published a review with Daniela entitled ‘An update on the use of rifapentine for tuberculosis therapy’ in Expert Opinion on Drug Delivery. Mehra was the first author on a publication in Pharmaceutical Research entitled ‘In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers’. This article describes the establishment and validation of a modified Anderson Cascade impactor for study drug transport across lung epithelia. Jesslynn published two articles as first author.  Firstly, she published an education article entitled ‘Graphing software for medical writers in the Journal of Medical Writing. Secondly, she published an article in Pharmaceutical Research entitled ‘Isothermal Calorimetry: A predictive tool to model drug-propellant interactions in pressurized metered dose systems’. This later article focusses on realtime monitoring of phase transitions in pMDI systems.

The group has come a long way in 2013 and we thank all our supporters and followers. We wish everyone a prosperous 2014 and look forward to the year ahead.

Respiratory Technology @ the WIMR Congratulations Graduating Student

YY, Michele, Mariateresa & Eric

YY, Michele, Mariateresa & Eric

Hui Xin Ong (YY) was awarded the degree Doctor of Philosophy by the University of Sydney in an official graduation ceremony. YY started her PhD in 2010 in the Faculty of Pharmacy under the supervision of Paul Young, Daniela Traini (WIMR) and Mary Bebawy (UTS). YY submitted her thesis, entitled 'TRANSPORT MECHANISMS OF INHALED CIPROFLOXACIN FORMULATIONS ACROSS CALU-3 LUNG EPITHELIA' within 3 years of commencing. Dr YY has been employed at the Woolcock Institute of Medical Research (WIMR) since March 2013 as a Postdoctorate Researcher in Respiratory Technology. YY  has made an outstanding achievement as an early career researcher and has already published 7 research articles in high impact journals within her field, as well as a number of peer reviewed full conference papers. YY has been awarded a European Respiratory Society Postdoctoral fellowship and will move to the UK in early 2014 to commence a clinical focussed research project with Prof Joy Conway’s group in the area of medical imaging.

John Chan awarded best ECR talk at ECR2STAR 2013

John Chan receiving award from Dr David Lewis (Chiesi UK Ltd) with PhD supervisor A/Prof Daniela Traini

John Chan receiving award from Dr David Lewis (Chiesi UK Ltd) with PhD supervisor A/Prof Daniela Traini

John Chan was awarded best early career speaker during the ECR2STAR workshop and conference held in London this December. 60 early career researchers and established academics attended the conference to discuss opportunities and hints and tips for becoming a leader in academia and industry. In the afternoon 11 ECRs showcased their work. John’s received an award for his talk on targeting TB and received a certificate and £200.

Royal Society of NSW award for John Chan

John Chan

John Chan

John Chan has been awarded a scholarship from the Royal Society  of NSW acknowledging his outstanding achievements as a young researcher. John, a postgraduate researcher in the Respiratory Technology group at the Woolcock Institute and Sydney Medical School, will receive the award and give a presentation at the society's general meeting and a paper for the Society's Journal in the new year. The award consists of a certificate acknowledging achievement, a $500 prize and a complimentary year of membership to the Society. 

You can learn more about the society and award here

Woolcock & ISAM to host 2014 Joint Conference & Workshop in Sydney

ISAM_WIMR 2014_Bumper Sticker.jpg

ISAM-Woolcock Institute Joint Conference on “Translating Advances in Understanding Lung Disease into Innovative Inhaled Therapeutics”The Woolcock Institute in Sydney, Australia is leading advances in understanding the mechanisms of lung diseases at the cellular level; it also has a long history of treating patients and improving their compliance through education and training on use of inhalers.  In between these two ends of the research spectrum is the effort to translate the advances in basic science into innovative therapeutic products that will make a difference in these patients’ lives.  To this end, ISAM and its members at the Woolcock Institute are planning a joint conference focused on “Translating Advances in Understanding Lung Disease into Innovative Inhaled Therapeutics” scheduled for September 25-26, 2014 in Sydney, Australia.  Please check the ISAM  www.isam.org and Woolcock www.woolcock.org.au websites regularly for more updates.

SPIRITUS: (11) A Monthly update from the Respiratory Technology team at the WIMR

This is our November update of news from the Respitech group at the WIMR.

shutterstock_134750123.jpg

In November, the RespiTech group has participated in a number of events. Firstly, we were involved in the Woolcock ‘Think Tank’, a two day conference that highlights the institute’s research strengths and identifies strategic directions for future projects and collaborations. Judy Loo gave an excellent presentation on modified intubation tubes for reducing pneumonia infection in ICU patients and Wing-Hin participated in the Woolcock’s ECR Translational Research Grant, pitching a novel lung cancer therapy. Also, YY won a bottle of bubbly for being the most enthusiastic ECR participant!

The team participated in the annual Melbourne Cup celebrations at the Institute. Meanwhile, Dany Traveled to Italy to conduct a series lectures as Visiting Professor at the University of Ferrara, while Paul went to AAPS in San Antonio USA to establish a series of new collaborations.

Later in the month, the team participated in the Chancellor’s reception at the Woolcock to celebrate a series of Centres of Excellence, a Corporative Research Centre, and the Woolcock Advanced Microscopy Suite. Paul spoke about the new microscopy facilities which are now operational.

As usual we welcome and say goodbye to RespiTech members. This month we say goodbye to Amitabh Prakesh and Ningyi Xu. Amitabh completed his Hons thesis on cilia beat function and was awarded his degree at the end of November. Ningyi completed her Masters degree with the team in the area of pressurised metered dose inhaler droplet drying kinetics. We wish both all the best in their future career. 

We would like to congratulate Eric (Bing Zhu) for being awarded his PhD from the University of Sydney. Erics’s thesis is entitled “The influence of formulation variables on particles generated from solution based pressurised metered dose inhalers”. Eric will continue working with the group as a postdoctoral scientist within the field of aerosol generation.

We would also like to congratulate Alaa Tulbah and Yang Chen for giving excellent PhD presentations at the Woolcock’s Friday morning seminars.

Lastly, we would like to congratulate Yang and Eric for publishing two papers this month. Yang was the first author on a publication in ‘Pharmaceutical Research’ entitled ‘The influence of actuator materials and nozzle designs on electrostatic charge of pressurised metered dose inhaler (pMDI) formulations’ while Eric was the first author on a paper in ‘Colloids and Surfaces A’ entitled ‘The solid-state and morphological characteristics of particles generated from solution-based metered dose inhalers: influence of ethanol concentration and intrinsic drug properties’. Both these publications focus on one of areas of interest of the group- pMDI technology, and the study of particle properties after aerosol generation.


Woolcock Think Tank 2013

Alaa and Yang give woodcock seminar

Chancellors reception

SPIRITUS: (10) A Monthly update from the Respiratory Technology team at the WIMR

shutterstock_120571951.jpg

This is our October update of news from the Respitech group at the WIMR.

October has been a hectic yet productive month for the Respitech group. Firstly the team hosted the Drug Delivery Australia Conference (DDA 2013) at the Woolcock Level 5 conference venue. 100 national and international delegates participated and we had keynote speakers Igor Gonda (Aradigm) and Ian Tucker (current president of the CRS) give insightful talks on the future of drug development and delivery. The conference ran over 2 days and covered a range of topics including respiratory drug delivery, cancer targeting and novel drug delivery vehicles. There were a number of student prizes, great food, a highly popular ice-cream cart and a cruise on the harbour. Thanks to the whole team for all the effort they have put in to make this a success!

DDA2013 Delegates

DDA2013 Delegates

Meanwhile, the ECR2STAR program is picking up pace. We are already approaching capacity for our first workshop in London and have finalised the academic and industrial speakers. The web-site has been visited by 2000 people and we have contributors from around the globe participating with articles and comments via Facebook and Linkedin. If you are a early career research and want to learn more visit ecr2star.org.

Back at the Institute, members of the group have been busy working to develop the Woolcock’s new profile and have successfully launched the new woolcock.org.au web portal. This was completed in time for the Governor of New South Wales reception for the Institute, held at Government house in Sydney which Paul attended on behalf of the Respiratory Technology Group.

We would like to congratulate YY (Hui Xin Ong) for being awarded her PhD from the University of Sydney. YY’s thesis is entitled ‘Transport Mechanisms of Inhaled Ciprofloxacin Formulations Across Calu-3 Lung Epithelia’ YY will continue working with the group and spend next year applying the findings from her thesis to transport kinetics of drugs in humans, using scintigraphic techniques at Southampton Hospital in the UK.

Lastly, we would like to congratulate John Chan and Alessandro  Sadat for publishing two papers this month. John was the first author on a paper published in Pharmaceutical Research, focussing on novel inhaled anti-tuberculosis drugs while Alessandro ’s paper in Journal of Pharmacy and Pharmacology described a inhaled macrolide formulation designed to target bronchiectasis.

 

SPIRITUS: (09) A Monthly update from the Respiratory Technology team at the WIMR

This is our September update of news with the RespiTech group at the WIMR

Sept.jpg

September has been an exciting month with the establishment of a series of new initiatives.

Firstly, we have launched a new initiative for young researchers: www.ecr2star.org. Early career researcher to research star (ECR2STAR) is a global initiative to encourage early career researchers (PhD, PostDocs and early career academics and industry researchers) to become the next leaders in their field. 

We have established a website that will be a repository of useful information, news, links and opportunities for ECRs. Additionally, the group has announced the first free ECR2STAR workshop, to be hosted in London this December as part of a collaborative project between University College London, University of Sydney and the Woolcock Institute of Medical Research. For more information follow the link www.ecr2star.org

Secondly, we launched SPAM (Strategic Promotion Advice and Mentoring). Daniela Traini at the WIRM together with colleagues Penny Oxford and Fiona White both from the Faculty of Science, have organized the very first ‘Promotions myths and legends workshop’. Fifteen Level D women in Science, Vet Science, Agriculture and Environment and Medicine Interested in applying for Level E in 2014 or 2015 attended.  The next meeting will be held at the Woolcock Institute on Tuesday the 22nd of October 1-2.30pm. Please send Daniela an email if you are interested in attending. 

As always, we welcome members to the Respitech team. This month we have two new members, Gianluca Lauretani and Mariateresa Stigliani. Gianluca is a visiting student from The University of Ferrara (Italy) and will work on combination therapies for targeting muco-hypersecretion and bacterial infection in the lung, while Mariateresa is a PhD student from Salerno (Italy) who will be studying drug transport phenomena across lung epithelia. Welcome to both. 

We would also like to congratulate Gianluca on securing one of 8 scholarships valued at Euro 2500 (>$3500) from the Atlante-Rotary Club in Ferrara to support international mobility. Well done!

Finally, the DDA2013 program for the October conference has now been finalised and the event is shaping up to be a success. We are projected to have over 100 delegates with world-class speakers and abstracts. More on this in next month newsletter.

 

RespiTech Members launch a Free ECR2STAR workshop in London this December

Learn.jpg

Members of the RespiTech group are please to announce a workshop for young and early career researchers in the biomedical and drug delivery fields. The workshop will be held in collaboration with UCL members and will focus on career development. The workshop will also give ECRs the opportunity to speak about their research.

The ECR2STAR team is pleased to announce our first workshop for early career researchers in London this December. If you are a PhD student or early career researcher (ECR) postdoctoral scientist working in the area of drug delivery and biomedical science this workshop is for you!

 Learn how to get the most out of your research career

 Listen and interact with leaders in both academia and industry

Present your data to other ECRs and stand the chance to win £200

The conference will be held on the 9th December at Senate House in London (UK) and is brought to you by: University College London, The University of Sydney and The Woolcock Institute of Medical Research.  

Most importantly, this workshop is free!

You can register online at http://ecr2star.org/2013-conference/

 

SPIRITUS: (08) A Monthly update from the Respiratory Technology team at the WIMR

Firstly, we would like welcome Judy Loo, who will commence a research post within the group. Judy's research will be focussed on inhaled antibiotic and anti-biofilm therapies. During her PhD, Judy developed a series of antibacterial and biofilm resistant plastics that can be incorporated into intubation tubes for intensive care purposes. Judy undertook her PhD in the Faculty of Pharmacy, supervised by Ramin Rohanizadeh, Cynthia Whitchurch (UTS) and Paul Young. We would also like to congratulate her for a fantastic final thesis presentation at the Faculty earlier in the month. Both Judy and Wing-Hin submitted their thesis this month... Congratulations!

August.jpg

The group would also like to welcome Rebbeca Xu. Rebecca is a Masters student who will be undertaking a research program to develop advanced excipients for use in non-aqueous propellant and nebuliser based inhalation devices. Additionally we would like to invite four elective Pharmacology students who will be working with us, for the next few months, to gain experience in drug delivery. Welcome to Jacob Emilio, 'Jack' Ba Duy, Merrel Anna and Emelie Linnea.

Members of the RespiTech team have been busy preparing for DDA 2013. We have now confirmed international and domestic invited podium presenters and have two fantastic Keynote speakers, Igor Gonda and Ian Tucker. Igor is the CEO of Aradigm in San Francisco. He was also former CEO of Acrux and an academic at the University of Sydney. Ian is the incoming president of the CRS and Professor at the University of Otago, New Zealand. We have had a great response regarding abstract submissions and are looking forward to the social events, including a harbour cruise.

This month, the group have also been successful in securing funding for the establishment of a collaborative research program between Trinity College Dublin and Sydney. Dr. Carsten Ehrhardt will spend time at the Woolcock Institute working with our team to study the expression and function of transport proteins in the lung. Finally, members of the group have published an original article focussed on the preparation of macrolide nano-particles for drug delivery.

DDA-2013 Keynote Speakers and Preliminary Program Confirmed

With two weeks to the close of early bird registrations, the DDA-2013 team are excited to announce preliminary details of this year program. Keynote speakers Igor Gonda and Ian Tucker will be giving opening presentations across the two-day conference.  Igor is the CEO of Aradigm, a drug delivery company specialising in inhaled therapeutics and Ian Tucker is the incoming president of the CRS, specialising in bioactives drug delivery for human and veterinary applications.

In addition, we have confirmed a number of International and Domestic invited speakers from a wide range of drug delivery backgrounds. These talks will appeal to the diverse audience of DDA and be complimented with contributed poster and podium talks by registrants. Students are encouraged to participate in DDA and we have two prizes for the rapid-fire student talks; supporting travel to the CRS meeting in Chicago 2014. Lastly, you can let your hair down at the conference dinner, which will be an evening cruise on Sydney Harbour (included in your registration). We look forward to seeing you at DDA 2013!